|
Volumn 60, Issue 3, 2007, Pages 703-704
|
Detection of OXA-2 group extended-spectrum-β-lactamase-producing clinical isolates of Escherichia coli from India [2]
|
Author keywords
E. coli; ESBLs; OXA type
|
Indexed keywords
AZTREONAM;
BETA LACTAM;
BETA LACTAM ANTIBIOTIC;
BETA LACTAMASE INHIBITOR;
BETA LACTAMASE OXA 2;
CEFOTAXIME;
CEFPODOXIME;
CEFTAZIDIME;
CEFTRIAXONE;
EXTENDED SPECTRUM BETA LACTAMASE;
IMIPENEM;
PIPERACILLIN PLUS TAZOBACTAM;
TAQ POLYMERASE;
UNCLASSIFIED DRUG;
ANTIBIOTIC SENSITIVITY;
BACTERIAL GENE;
BACTERIAL STRAIN;
BACTERIUM ISOLATE;
DNA SEQUENCE;
ESCHERICHIA COLI;
GENETIC IDENTIFICATION;
INDIA;
LETTER;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
POLYMERASE CHAIN REACTION;
PROTEIN ANALYSIS;
ANTI-BACTERIAL AGENTS;
BETA-LACTAMASES;
DRUG RESISTANCE, BACTERIAL;
ESCHERICHIA COLI;
ESCHERICHIA COLI INFECTIONS;
HUMANS;
INDIA;
MICROBIAL SENSITIVITY TESTS;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
|
EID: 34548125393
PISSN: 03057453
EISSN: 14602091
Source Type: Journal
DOI: 10.1093/jac/dkm267 Document Type: Letter |
Times cited : (22)
|
References (6)
|